Botswana‑Harvard HIV Clinical Trials Partnership
Official title: Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU
Funded at The Botswana Harvard Health Partnership · NIH-11412843 · Data updated 2026-11-12
This program runs clinical trials in Botswana to test new HIV treatments, prevention methods, and tuberculosis care for adults, children, and pregnant women.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Botswana Harvard Health Partnership NIH-funded |
| Lab location | 1 site (Gaborone, Botswana) |
| Project start | February 1, 2007 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $2,118,250 |
| NIH project number | 7UM1AI069456-20 |
| Project ID | NIH-11412843 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are adults and children living with HIV in Botswana, including pregnant women, and people being treated for or at risk of tuberculosis.
✕Less likely to help
People without HIV, those who live far from the trial sites, or those who do not meet specific health or age criteria would likely not be eligible or directly benefit.
What this research studies
If you live in or near Gaborone or Molepolole, this partnership offers trials that test HIV medicines and prevention tools for adults, children, and pregnant women. The Clinical Trials Unit works with three international research networks to run studies on durable HIV treatments, strategies to reduce or stop daily antiretroviral therapy, and better care for HIV‑related infections like tuberculosis. Trials take place at clinics in both an urban center and a large village so people from different communities can join. Eligible participants receive care from experienced teams, regular monitoring, and may be asked to provide blood or other samples during follow‑up.
Why it matters
Potential benefit: If successful, the work could bring safer, longer‑lasting HIV treatments, strategies to reduce or stop daily antiretroviral therapy, and improved prevention and treatment for tuberculosis and related infections.
How similar studies have gone: Previous HIV and TB clinical trials have produced many effective treatments and prevention tools, though approaches aiming for ART‑free remission remain experimental.
Where this research is happening
-
The Botswana Harvard Health Partnership
Gaborone, Botswana Active
Researchers
- Principal investigator: Makhema, Joseph Moeketsi — The Botswana Harvard Health Partnership
- Study coordinator: Makhema, Joseph Moeketsi
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
New thin, flexible tactile displays to make screens accessible for people who are blind
A new thin film technology will let touch-based screens mimic visual displays, helping people who are blind or visually impaired use phones and other devices.
-
FIOCRUZ HIV/AIDS Clinical Trials Unit: advancing HIV prevention and treatment in Brazil
A Brazilian clinical trials unit led by Dr. Beatriz Grinsztejn is testing and speeding up new HIV prevention and treatment strategies to help people living with HIV/AIDS and those at risk.
-
Breeding colony expansion to support HIV/AIDS research with rhesus macaques
A funding opportunity to expand a specialized Rhesus macaque breeding population to support HIV/AIDS research at Tulane’s primate facility.
-
HIV Resilience Observatory in a rhesus macaque colony expansion
A program to build a rhesus macaque breeding colony and use AI-powered monitoring to study why some HIV/AIDS outcomes differ among individuals with similar backgrounds.
-
Indoor-Outdoor Housing Expansion to Support HIV/AIDS-Related Research
A HIV-focused project at a primate research center will use new indoor/outdoor housing and AI-assisted monitoring to study why people with similar backgrounds can have very different HIV outcomes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.